1. Home
  2. RGEN vs ALV Comparison

RGEN vs ALV Comparison

Compare RGEN & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ALV
  • Stock Information
  • Founded
  • RGEN 1981
  • ALV 1953
  • Country
  • RGEN United States
  • ALV Sweden
  • Employees
  • RGEN N/A
  • ALV N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ALV Auto Parts:O.E.M.
  • Sector
  • RGEN Health Care
  • ALV Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • ALV Nasdaq
  • Market Cap
  • RGEN 8.0B
  • ALV 7.2B
  • IPO Year
  • RGEN N/A
  • ALV 1997
  • Fundamental
  • Price
  • RGEN $126.50
  • ALV $101.93
  • Analyst Decision
  • RGEN Buy
  • ALV Buy
  • Analyst Count
  • RGEN 12
  • ALV 11
  • Target Price
  • RGEN $172.67
  • ALV $114.64
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • ALV 569.2K
  • Earning Date
  • RGEN 04-29-2025
  • ALV 04-16-2025
  • Dividend Yield
  • RGEN N/A
  • ALV 2.74%
  • EPS Growth
  • RGEN N/A
  • ALV 35.84
  • EPS
  • RGEN N/A
  • ALV 8.68
  • Revenue
  • RGEN $650,429,000.00
  • ALV $10,353,000,000.00
  • Revenue This Year
  • RGEN $13.93
  • ALV N/A
  • Revenue Next Year
  • RGEN $14.35
  • ALV $3.78
  • P/E Ratio
  • RGEN N/A
  • ALV $11.76
  • Revenue Growth
  • RGEN 4.88
  • ALV N/A
  • 52 Week Low
  • RGEN $102.97
  • ALV $75.49
  • 52 Week High
  • RGEN $182.52
  • ALV $129.38
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • ALV 70.29
  • Support Level
  • RGEN $123.10
  • ALV $100.05
  • Resistance Level
  • RGEN $135.47
  • ALV $102.40
  • Average True Range (ATR)
  • RGEN 6.98
  • ALV 1.72
  • MACD
  • RGEN -0.97
  • ALV 0.90
  • Stochastic Oscillator
  • RGEN 25.20
  • ALV 91.21

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About ALV Autoliv Inc.

Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.

Share on Social Networks: